Simplifying pediatric immunization with a fully liquid pentavalent vaccine: Evidence from a time-motion study

Similar documents
Exercise: Estimating immunization program costs (~60 minutes)

UNICEF Safe Injection Equipment Key highlights

Challenges of building a new vaccine delivery platform for LMICs

UNICEF s perspective. WHO Informal Consultation to develop further guidance on vaccines for the UNEP-convened INC4 Geneva, 3-4 April 2012

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017

SESSION SITES MONITORING OF ROUTINE IMMUNIZATION PROGRAM IN BIJAPUR DISTRICT

Expanded Programme on Immunization (EPI):

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

Impact of wastage on single and multi-dose vaccine vials: Implications for introducing pneumococcal vaccines in developing countries

A SURVEY ON IMMUNIZATION COVERAGE AMONG CHILDREN OF RURAL SOUTH KERALA M. C. Vasantha Mallika 1, Siva Sree Ranga M. K 2

City, University of London Institutional Repository

GAVI Alliance. Aurelia Nguyen, Director Policy & Market Shaping. IPC Meeting 30 May 2013

ASSESSMENT OF VACCINE WASTAGE IN A TERTIARY CARE CENTRE OF DISTRICT ROHTAK, HARYANA

WHO Recommendations and Guidelines for the Prevention of Perinatal Hepatitis B and Use of Hepatitis B Vaccines

Primary Vaccine Container Selection in Developing Countries Safety. Neal Halsey Johns Hopkins Bloomberg School of Public Heath

MenA vaccine Introduction Country Experience, Ethiopia

VACCINE MANAGEMENT. Recommendations for Handling and Storage of Selected Biologicals. January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES

Hepatitis B vaccination of newborns in rural China: evaluation of an out-of-coldchain delivery strategy. Istanbul, Turkey March 15-17, 2006

The Financial Sustainability of New Vaccine Introduction in the Poorest Countries :

Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG)

Dr. Collins Tabu KPA Conference, 26 th April 2018 Mombasa, Kenya

Frequently asked questions (FAQs) on MR vaccination campaign. Training Workshop for Measles-Rubella Vaccination Campaigns

Measles Immunization Catch-up Campaign

Requirements for new trials to examine offtarget. vaccination. Workshop on: Off-target (heterologous/non-specific) effects of vaccination.

Indicative operational, financial and environmental impact of Thiomersal-free vaccines

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV

Gavi s Vaccine Investment Strategy

COMBINATION VACCINE - THE IMPORTANCE AND ROLE IN PUBLIC HEALTH SET UP

Introduction of Haemophilus influenzae type b vaccine into immunization programmes

Vaccines. Global impact of a preventive technology. Edwin J. Asturias, MD

Access to Vaccines: Where are we, Why are we there, Where do we need to get to? Martin Friede Initiative for Vaccine Research

Global landscape analysis and literature review of 2 nd Year of Life immunization platform

Polio and measles control: opportunities and threats for health systems

Global update on temperature monitoring

Frequently asked questions (FAQs) on MR vaccination campaign

Managing constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October Bangkok,

Dr. Collins Tabu 24 th April 2018 Nairobi, Kenya

Year: 2017 Volume:5 Issue-1 Introduction of newer vaccines in Immunization Programme of India: Challenges to be addressed

Government of Bangladesh

H1N1 Vaccine Based on CDCs ACIP Meeting, July 29, 2009

Global Epidemiology and Prevention of Hepatitis B

Overall presentation of IVR Strategy

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 5. Can my country afford a JE vaccination program?

HEALTHCARE DESERTS. Severe healthcare deprivation among children in developing countries

BCG. Program Management. Vaccine Quality

Program: Expanding immunization coverage for children

Adolescent Health programme and its contribution to the success of vaccination in Finland

Presentation to 13th Annual General Meeting of the DCVMN UNICEF Vaccine Forecasting

Nigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision

Message from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization

UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013

At a glance: Nigeria. Statistics. 1 von 15 14/11/ :41. Basic Indicators

Global Health Policy: Vaccines

Towards the Achievement of GHSA 2024 s Overarching Targets

TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE

Annex 7a. Evaluation of routine second dose measles vaccination (health facility based implementation)

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

Access to vaccination in GAVI countries and at global level

Principles and considerations for adding a vaccine into a national immunization programme

Primary Vaccine Container Roundtable: Modeling

This document was published by: The National Department of Health. Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo

National Immunisation News

Expanded Programme on Immunization

7Monitoring and using your data

WHITE PAPER. A Summary of Global Immunization Coverage through David W Brown, Anthony H Burton, Marta Gacic-Dobo (alphabetical order)

Why does Diarrhea matter? PREVENTING MORE THAN ONE MILLION UNNECESSARY DEATHS EVERY YEAR

Costing in Vaccine Planning and Programming

WHO Strategy and Goals for Viral Hepatitis Elimination

Training for Inactivated Poliovirus Vaccine (IPV) introduction. Module 8. Safety and acceptability of multiple injections

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

VERSION APPROVAL PROCESS NUMBER 1.0 Nina Schwalbe, Managing Director, Policy and Performance

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

Sudan EPI Benefits From Polio Eradication Program

Pentabio Vaccine (DTP-HB-Hib)

Temperature monitors for vaccines and the cold chain

From: New York State Department of Health, Bureau of Communicable Disease Control, Immunization Program

Let s Fight Flu Together! School-Based Influenza Immunization Initiative

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m.

Table 1: Basic information 2017

INSTRUCTOR S NOTE. Copyright 2018, The Johns Hopkins University and Teaching Vaccine Economics Everywhere.

Paradigm shift: from dependency to country ownership Seth Berkley, MD Chief Executive Officer of the GAVI Alliance

Expanded Programme on Immunization (EPI)

Selected vaccine introduction status into routine immunization

Maternal Newborn and Child Health

THE COMPLEX JOURNEY OF A VACCINE PART II Immunization Supply Chain, Delivery Innovation, and Regulatory Requirements

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.

Introduction of new vaccines: public health - policy decisions and programmatic implications

WHY WE RE HERE. Melinda Wharton, MD, MPH Director, Immunization Services Division. National Center for Immunization & Respiratory Diseases

Opportunities and challenges with introduction of newer vaccines: What is needed from the next generation of vaccines

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector

Texas Immunization Coverage Levels TVFC Conference-Permian Basin April 20, 2016

Programme update. Prequalification of Vaccines

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

C o n t e n t s. > Immunizations 4. > Diphtheria 6. > Pertussis 7. > Tetanus 8. > Polio 9. > Measles 10. > Tuberculosis 11.

Vaccine Security UNICEF Vaccine Procurement Overview. Supplier meeting UNICEF Supply Division 3-4 April 2008 Rob Matthews

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Published in WER 4 June, 2010

increased efficiency. 27, 20

Shabir A. Madhi. Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality.

Expanded Programme on Immunization (EPI)

Transcription:

Simplifying pediatric immunization with a fully liquid pentavalent vaccine: Evidence from a time-motion study Dr. Karin Anne Wiedenmayer Swiss Tropical Institute Basel, Switzerland February 2008 1

Value of immunization Immunization is one of the most cost-effective public health interventions Immunization programs strengthen health systems Integration of other public health interventions: ITN, vitamin A, intestinal worms, nutrition Cost-benefit analysis in the USA: $1 invested in vaccines saves $2-27 of health expenses Study on the value of immunization programs in LICs: improves health, averts illness, saves lives improves cognitive and educational development, and boosts economies Bloom D, et al. World Economics 2005 2

Achievements and challenges Immunization programs have saved 2.3 million lives since 2000 Significant contribution to prevention and containment of infectious disease Effective immunization programs promote sustainability by yielding healthier population and stronger economies New vaccine technology available but unevenly spread But Immunization programs still don t reach all children of this world 3

Childhood immunization worldwide Routine vaccination in low income countries DTP, BCG, OPV, and measles HepB and Hib recommended by WHO 28 million children not immunized (one in four) in 2005 Estimated 1.5 million children <5 years old die of vaccine-preventable diseases every year 4

DTP and HepB coverage globally Global coverage of infants with three doses of DTP in 2004 78% Global coverage of infants with three doses of HepB in 2004 48% Global immunization data, WHO 2004 5

DTP and HepB coverage in Egypt Coverage of infants with three doses of DTP in 2007 98% Coverage of infants with three doses of HepB in 2007 98% WHO data, 2007 6

Global goals and challenges MDG Reduce child mortality Access to new and underused vaccines Increase coverage Strengthen immunization programs Strengthen health systems Effective and easy to use technology 7

Combination vaccines Simplicity, efficiency, safety Vaccine shipping, handling, and storage Vaccine delivery and administration Immunization management Waste (vaccines, syringes, and safety boxes) Office time needed to deliver vaccines Reduced number of injections for children Timely and complete protection Adherence to vaccination schedules Introduction of new vaccines in EPI systems Marcy SM, Am J Manag Care 2003; Decker et al. In Vaccines 2004; Kalies et al. Peditr Infect Dis J 2006 8

Fully liquid polyvalent combination vaccines Advantages for the recipient and healthcare provider ready to inject in a few seconds no reconstitution simplifies logistics and saves resources minimizes risk of contamination and handling errors meets the EPI objective of minimizing waste saves delivery time 9

Fully liquid DTP-HepB-Hib combination vaccines Goal of vaccine delivery: Simplicity, efficiency, safety Advantages and benefits! Advantages and benefits? Needed: supportive evidence and models 10

Time-motion study Objectives To study the time and programmatic implications of delivering a fully liquid vs lyophilized vaccine requiring reconstitution DTP-HepB-Hib (1 vial * ) vs DTP-HepB + Hib (2 vials ** ) * Easy5, Chiron-Panacea; ** Tritanrix-HepB + Hiberix, GSK 11

Fully liquid vaccines vs lyophilized vaccine Lyophilized vaccine transfer withdraw add shake to reconstitute withdraw and inject Fully liquid vaccine 12

Methodology (I) Time-motion study Observational comparative case study Institute of Child Health (ICH), Calcutta, India Actual program setting Fully liquid vs lyophilized pentavalent vaccine Alternating vaccines with each child Timing and recording five vaccination steps Questionnaires Ethical clearance 13

Methodology (II) Time-motion study variables 1. Obtain 2. Prepare vaccine 3. Administer 4. Dispose 5. Document 6. Overall duration of vaccine visit 14

Methodology (III) Vaccination campaign Television, radio, newspaper, flyers, banners, community mobilization, whispering campaign Free vaccination for eligible children with full immunization schedule (three doses) Vaccines provided: DTP, HepB, Hib, and polio 15

Results Comparison of a fully liquid and a lyophilized pentavalent combination vaccine Children vaccinated (n=312) Two data collectors: same results Competent, experienced, and efficient vaccination team 16

Time differences between vaccines by vaccination step 03:50 03:21 02:52 02:24 01:55 01:26 * 00:57 00:28 * 00:00 Fully liquid Lyophilized * * * *p<0.05 vs. lyophilized vaccine 17 Time (minutes) Obtain Prepare Administer Dispose Document Cumulative time Overall visit duration Vaccination step

Time differences between vaccines Time (minutes) 02:24 02:09 01:55 01:40 01:26 01:12 00:57 00:43 00:28 00:14 00:00 Fully Liquid Vaccine Lyophilized Document Dispose Administer Prepare Obtain 18

Delivery time savings Fully liquid pentavalent combination vaccine 53% time savings for preparation of vaccine 24% time savings for total vaccination visit Improved convenience Easier handling and preparation Less emotional stress for children 19

Potential delivery time savings: illustrative examples for fully liquid vaccine ICH Calcutta: 20 working days per year Assumptions: Current workload of 50 children vaccinated per day ICH open 5 days a week and 48 weeks per year India: 100,000 working days per year Assumptions: EPI coverage for DTP3 in 2004: 64% Live births 27.5 million Infant mortality rate: 68 per 1000 live births One working day = 6 hours 20

Economic implications for South Africa To assess potential implications of introducing fully liquid pentavalent DTP-HepB- Hib vaccine into national EPI program in South Africa DTP-HepB-Hib (1 vial)* *Quinvaxem, Novartis Vaccines 21

Economic and financial assessment: Comparison in South Africa DTP-HepB-Hib vs DTP-Hib + HepB + Fully liquid pentavalent vaccine Currently used in South Africa 22

Components of economic analysis Time savings (1min) Salary package of vaccination nurse (10 000$) Number of children vaccinated (1 mio/year) Vaccine doses Wastage rate (multidose vs single vial) Syringes, needles, safety boxes Storage and distribution Waste management Training costs 23

Potential economic implications for South Africa Fully liquid pentavalent DTP-HepB-Hib vaccine compared to currently used vaccines in South Africa Cost savings: US$ 2.5 mio Reduction in delivery time: 7700 working days 24

Conclusion Programmatic implications Fully liquid pentavalent DTP-HepB-Hib vaccine Simplicity of vaccine delivery Alleviate immunization workload Vaccination coverage, health system performance 25

Conclusion Financial and economic implications Fully liquid pentavalent DTP-HepB-Hib vaccine Cost savings Efficiency gains at health facility level Health workers shortage 26

Acknowledgements Fabrizio Tediosi, Swiss Tropical Institute Svenja Weiss, Swiss Tropical Institute SBDevi Charity Home, Calcutta, India Institute of Child Health Calcutta, India This study was financially supported by Novartis Vaccines 27

Acknowledgements 28

Acknowledgements 29